(Q44497842)

English

In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development

scientific article published in July 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

D Bresters

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A J F Broekhuizen

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

P Kaaijk

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

G T Faircloth

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

J Jimeno

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

G J L Kaspers

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1338-1343

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Drug combination testing in acute lymphoblastic leukemia using the MTT assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors. comparison with the clinical results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Gemcitabine in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

21 January 2018

Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of cellular drug resistance in childhood leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402972

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402972

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44497842&oldid=2206689555"